NX
NEXGEL, Inc.
NXGL · NASDAQ
$0.27 +5.81% (+$0.01)
1M -19.45%
Market Cap $2.12M
P/E Ratio -
Div. Yield -
ROE 133.10%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.18x
P/B 0.43x
P/E N/A
Growth
78 /100
Growing Rev. growth 77.33%
Book val. growth 16.42%
EPS growth N/A
Profitability
14 /100
Weak Gross margin 35.07%
Net margin 51.26%
FCF margin 27.10%
Quality
6 /100
Poor ROIC 42.52%
ROE 133.10%
Asset turnover 0.46x
Debt
17 /100
High Debt/Equity 1.49x
Current ratio 0.43x
Int. coverage -1.73x
Stability
56 /100
Moderate Beta 0.75x
Rev. volatility 43.55%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NXGL
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Brian J. Kieser
Employees
19
Headquarters
Langhorne
Upcoming events
10 NOV
Earnings
Upcoming earnings report